Join today and have your say! It’s FREE!

We will not release or resell your information to third parties without your permission.

Please Try Again

By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

Please Try Again

Password Hint : {{passwordHint}}

Remember me

Forgot Password?

News Focus

LQWD Technologies Lightning Network Infrastructure Surpasses 1 Million Global Transactions (click to learn more)

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Healthcare

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

Add To Watchlist

Bullboard (TSX:GUD)

View:

Comment by longrun86on Aug 10, 2023 12:45pm

RE:RE:Updated Outlook

Thanks for your post. I agree with you that BD is underperforming. The operations also are underperforming from a profitability standpoint. The operating income margins should be much higher. I am ...more

135

Discussion

Comment by EbbFlow88on Aug 10, 2023 12:04pm

RE:Updated Outlook

Seems like a mixed bag. Higher sales which is great to see along with continued flow through of product pipeline. A lot of submissions of recent products. I think BD is having a tough time ...more

102

Discussion

Pharmaceutical Tech Co Reports 2.7X Revenue Growth Year-Over-Year at US $24 Million

posted Nov 21, 2024 9:00am by Innocan Pharma Corp

"Our strong operational and financial momentum continued throughout 2024 and now in the third quarter, we again demonstrated solid financial results. We are pleased to report nine consecutive quarters of continuous revenue growth. Our online platform continues to perform exceptionally well, contributing to our strong nine-month revenue growth of 174% YoY ...read more

Comment by Chianchinon Aug 10, 2023 9:02am

RE:Updated Outlook

..and they keep losing money and lower cash as they keep overpaying for share buy back. paradoxically MNGT is very proud of their ten years record

Discussion

Post by gudisgoodon Aug 10, 2023 7:40am

Updated Outlook

Updated Outlook: Revenue: $300-$320M to $310-$330M Adjusted EBITDA: 14-15% to 16-17%

190

Discussion

(0)
•••

Post by PressReleaseon Aug 10, 2023 7:30am

New Press Release - Knight Therapeutics Reports Second Quarter 2023 Results

- Achieves Record Revenues MONTREAL, Aug. 10, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) ("Knight" or “the Company”), a leading pan-American (ex-US) specialty pharmaceutical company, today reported financial results for its second quarter ended June 30, 2023. All currency...read article.

Comment by Chianchinon Aug 08, 2023 5:29am

RE:RE:Earning report prediction

Hey...micky mugsy ..still waiting for the Genie to show up? it was and still is a fairytale !!!!! however your investment account balance deep in red and not much $$$$ left 10 years later is a ...more

Discussion

Comment by MrMugsyon Aug 07, 2023 6:52pm

RE:Earning report prediction

I'm pretty sure Paladin never played the blame-game. Don't think Knight is going to play the blame-game. They provide the numbers and they give shareholders an understanding of what they see ...more

116

Discussion

Post by Chianchinon Aug 07, 2023 8:34am

Earning report prediction

What, how who will GUD blame for another bad quarter. Any guess

102

Discussion

(0)
•••

Post by PressReleaseon Aug 03, 2023 8:32pm

New Press Release - Notice of Knight Therapeutics' Second Quarter 2023 Results Conference Call

MONTREAL, Aug. 03, 2023 (GLOBE NEWSWIRE) -- Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2023 financial results on Thursday, August 10, 2023 prior to market opening. Following the release, Knight...read article.

Post by GoldenInvestoron Aug 02, 2023 3:21pm

Ardelyx posted results today

Our provider of tenapanor. infer our sales of tebapanor for IBS-c + are going strong.

123

Comment by Chianchinon Aug 01, 2023 12:42pm

RE:RE:RE:RE:RE:Mr Mugsy & three type of self investors

Only pie in the sky hopeless hope from bag holders nothing new same of the same in the past 10 Year and one billion in cash most gone to LATAM and no return yet. Latan is known for currency ...more

Discussion

Comment by EbbFlow88on Aug 01, 2023 12:29pm

RE:RE:RE:RE:Mr Mugsy & three type of self investors

We could have easily already hit bottom. TIme will tell. Volume has dropped noticeably in the last couple of months, which could be a function of an increasingly smaller float. Knight keeps ...more

101

Discussion

Comment by longrun86on Aug 01, 2023 11:02am

RE:RE:RE:Mr Mugsy & three type of self investors

For what it's worth, I bought more shares yesterday. I do expect them to start to deliver on some of the strategic initiatives that they have been alluding to. LR

Discussion

Comment by Chianchinon Aug 01, 2023 4:10am

RE:RE:RE:Mr Mugsy & three type of self investors

I agree GUD and ATE for the few selected losers

Discussion

The Market Update

< Previous bulletin

Next bulletin >

A daily snapshot of everything
from market open to close.

< Previous

Next >

Dealroom for high-potential pre-IPO opportunities

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s): KHTRF

Join the community and start posting on the bullboards today. It's free.

Create a portfolio watchlist today. It's free.

Bullboard (TSX:GUD)